Combivent HFA

DRUG2 trials

Sponsors

Boehringer Ingelheim

Conditions

Pulmonary Disease, Chronic Obstructive

Phase 2

A Confirmation Study of Combivent HFA Inhalation Aerosol in Patients With Chronic Obstructive Pulmonary Disease (COPD)

CompletedNCT02182674

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-10-31Updated: 2018-08-31

Phase 3

Comparison of Safety and Efficacy of COMBIVENT HFA to COMBIVENT (CFC) in Patients With Chronic Obstructive Pulmonary Disease (COPD)

TerminatedNCT02194205

Boehringer IngelheimPulmonary Disease, Chronic Obstructive

Start: 2000-10-31Updated: 2014-07-18